4.6 Review

Recessive cerebellar and afferent ataxias - clinical challenges and future directions

期刊

NATURE REVIEWS NEUROLOGY
卷 18, 期 5, 页码 257-272

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41582-022-00634-9

关键词

-

向作者/读者索取更多资源

In this Review, the authors discuss recessive ataxias with ganglionopathy or polyneuropathy, focusing on Friedreich ataxia and RFC1-associated cerebellar ataxia, neuropathy, vestibular areflexia syndrome. They explore the shared pathogenic mechanisms and therapeutic advances in these diseases. The Review also provides insights into the diagnostic challenges and clinical features of these diseases.
In this Review, the authors discuss recessive ataxias with ganglionopathy or polyneuropathy - particularly Friedreich ataxia and RFC1-associated cerebellar ataxia, neuropathy, vestibular areflexia syndrome - including the possible shared pathogenic mechanisms between these diseases and therapeutic advances. Cerebellar and afferent ataxias present with a characteristic gait disorder that reflects cerebellar motor dysfunction and sensory loss. These disorders are a diagnostic challenge for clinicians because of the large number of acquired and inherited diseases that cause cerebellar and sensory neuron damage. Among such conditions that are recessively inherited, Friedreich ataxia and RFC1-associated cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS) include the characteristic clinical, neuropathological and imaging features of ganglionopathies, a distinctive non-length-dependent type of sensory involvement. In this Review, we discuss the typical and atypical phenotypes of Friedreich ataxia and CANVAS, along with the features of other recessive ataxias that present with a ganglionopathy or polyneuropathy, with an emphasis on recently described clinical features, natural history and genotype-phenotype correlations. We review the main developments in understanding the complex pathology that affects the sensory neurons and cerebellum, which seem to be most vulnerable to disorders that affect mitochondrial function and DNA repair mechanisms. Finally, we discuss disease-modifying therapeutic advances in Friedreich ataxia, highlighting the most promising candidate molecules and lessons learned from previous clinical trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据